Foresight Dx
<UNKNOWN> · 2 known investors
Foresight Diagnostics develops ultra-sensitive diagnostic tests using genomics and bioinformatics to detect minimal residual disease in cancer patients, serving clinical and biopharma partners in oncology drug development and patient care.